The most frequent VH genes used in unmutated and mutated B-CLL across 4 studies
Homology to germline VH gene . | Unmutated/mutated cases, by study* . | |||
---|---|---|---|---|
No. 1 . | No. 2 . | No. 3 . | No. 4 . | |
VH1-69 | ||||
Below 98% | 21/0 | 8/2 | 5/1 | 9/1 |
Below 96% | NM | 8/2 | 5/1 | 9/1 |
VH3-07 | ||||
Below 98% | 0/4 | 0/5 | 1/8 | 0/5 |
Below 96% | NM | 1/4 | 1/8 | 0/5 |
VH3-21 | ||||
Below 98% | 2/13 | 0/1 | 0/0 | 1/1 |
Below 96% | 12/3 | 0/1 | 0/0 | 1/1 |
VH3-23 | ||||
Below 98% | 0/3 | 0/7 | 2/1 | 3/8 |
Below 96% | NM | 1/6 | 2/1 | 4/7 |
VH3-30 | ||||
Below 98% | 2/4 | 3/8 | 2/0 | 6/4 |
Below 96% | NM | 4/4 | 2/0 | 6/4 |
Total number of patients | 119 | 74 | 64 | 84 |
Overall frequency of cases, unmutated/mutated cases, % | ||||
Below 98% | 58/42 | 35/65 | 48/52 | 45/55 |
Below 96% | NM | 47/53 | 55/45 | 57/43 |
Template type on which analysis was performed | DNA | DNA | RNA | RNA or DNA |
Forward primer(s) | VH1 to VH6 | FR1/2† | VHL1 to VHL6 | VH1 to VH6 |
Reverse primers(s) | JH | JH cons† | CH | JH |
Homology to germline VH gene . | Unmutated/mutated cases, by study* . | |||
---|---|---|---|---|
No. 1 . | No. 2 . | No. 3 . | No. 4 . | |
VH1-69 | ||||
Below 98% | 21/0 | 8/2 | 5/1 | 9/1 |
Below 96% | NM | 8/2 | 5/1 | 9/1 |
VH3-07 | ||||
Below 98% | 0/4 | 0/5 | 1/8 | 0/5 |
Below 96% | NM | 1/4 | 1/8 | 0/5 |
VH3-21 | ||||
Below 98% | 2/13 | 0/1 | 0/0 | 1/1 |
Below 96% | 12/3 | 0/1 | 0/0 | 1/1 |
VH3-23 | ||||
Below 98% | 0/3 | 0/7 | 2/1 | 3/8 |
Below 96% | NM | 1/6 | 2/1 | 4/7 |
VH3-30 | ||||
Below 98% | 2/4 | 3/8 | 2/0 | 6/4 |
Below 96% | NM | 4/4 | 2/0 | 6/4 |
Total number of patients | 119 | 74 | 64 | 84 |
Overall frequency of cases, unmutated/mutated cases, % | ||||
Below 98% | 58/42 | 35/65 | 48/52 | 45/55 |
Below 96% | NM | 47/53 | 55/45 | 57/43 |
Template type on which analysis was performed | DNA | DNA | RNA | RNA or DNA |
Forward primer(s) | VH1 to VH6 | FR1/2† | VHL1 to VHL6 | VH1 to VH6 |
Reverse primers(s) | JH | JH cons† | CH | JH |